Innovation sharing a remedial measure: the case of Covid-19 pandemic
Abstract
Purpose
This study has aimed to analyse the role of innovation-sharing collaboration in the large-scale manufacturing of Covid-19 vaccination across the globe and its impact on the mortality rate of the countries where the pharmaceutical manufacturers received such innovation.
Design/methodology/approach
The authors have relied upon the difference-in-difference (DID) approach by utilizing the data available on public platforms such as World Health Organization (WHO) databank, organization for economic co-operation and development (OECD) data bank, istat, Indian bureau of statistics and European centre for disease prevention and control (ecdc) from 2020 to 2021 to establish the empirical inference of the analysis.
Findings
This study’s results present that after the invention and commercialization of the vaccine, the Covid-19 impact was still intact and people were dying continuously. However, it was impossible to fulfil the demand of the 7 billion population in a short time. In the light of these facts, the WHO encouraged sharing vaccine innovation with other countries to enhance production capacity. The authors found that after vaccine innovation sharing, Covid-19’s devastation slowed: the fatality rate was marginally reduced, and economic conditions started their recovery journey.
Originality/value
This study’s findings present that the Covid-19 vaccine played a pivotal role in tackling the Covid-19’s devastating impact on the entire world. It emphasizes the role of innovation-sharing collaborations in curtailing hazardous consequences, including the mortality rate during a crisis, and such collaborations’ impact on the countries where institutions involved in them reside.
Keywords
Acknowledgements
This work was supported by the National Social Science Foundation research on the Realization Mechanism and Breakthrough Path of the Key Core Technologies of Innovation Chain and Industrial Chain Coupling under Grant No22 & ZD094 and the National Natural Science Foundation of China under Grant Nos. 71701191 and 72174107. All errors are the authors’.
Citation
Ali, S., Ashraf, J., Ghufran, M., Xiaobao, P. and Zhiying, L. (2023), "Innovation sharing a remedial measure: the case of Covid-19 pandemic", European Journal of Innovation Management, Vol. ahead-of-print No. ahead-of-print. https://doi.org/10.1108/EJIM-05-2022-0290
Publisher
:Emerald Publishing Limited
Copyright © 2022, Emerald Publishing Limited